Cargando…
Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer
BACKGROUND: CK1 is involved in regulating Wnt/β-catenin signaling and represents a promising target for the treatment of breast cancer. A purine derivative longdaysin has recently been identified as a novel modulator of cellular circadian rhythms through targeting the protein kinases CK1δ, CK1α, and...
Autores principales: | Xiong, Yanpeng, Zhou, Liang, Su, Zijie, Song, Jiaxing, Sun, Qi, Liu, Shan-Shan, Xia, Yuqing, Wang, Zhongyuan, Lu, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368421/ https://www.ncbi.nlm.nih.gov/pubmed/30787621 http://dx.doi.org/10.2147/OTT.S193024 |
Ejemplares similares
-
Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β-catenin signaling
por: Sun, Qi, et al.
Publicado: (2019) -
Tumor promoter TPA activates Wnt/β-catenin signaling in a casein kinase 1-dependent manner
por: Su, Zijie, et al.
Publicado: (2018) -
Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
por: Yu, Shubin, et al.
Publicado: (2018) -
Salinomycin exerts anti‐colorectal cancer activity by targeting the β‐catenin/T‐cell factor complex
por: Wang, Zhongyuan, et al.
Publicado: (2019) -
Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer
Cell Through Antagonizing Wnt/β-catenin Signaling
por: Ye, Ling, et al.
Publicado: (2021)